Cidara Therapeutics, Inc. (CDTX) Net Income by Year
Cidara Therapeutics, Inc. reported a net loss of $169.8M in fiscal year 2024. This represents a decrease of 640.6% from the prior fiscal year. The table below carries 12 fiscal years, from 2013 to 2024, and the quarters Cidara Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CDTX Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
CDTX Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Cidara Therapeutics, Inc. financials
Frequently Asked Questions
What was Cidara Therapeutics, Inc.'s net income in fiscal year 2024?
Cidara Therapeutics, Inc. reported a net loss of $169.8M in fiscal year 2024.
How fast is Cidara Therapeutics, Inc.'s net income growing?
Cidara Therapeutics, Inc. (CDTX) net income fell by 640.6% year over year, from -$22.9M to -$169.8M in fiscal year 2024.
How has Cidara Therapeutics, Inc.'s net income changed over the years?
Across the 12 fiscal years this page covers, Cidara Therapeutics, Inc. (CDTX) net income went from -$1.3M in fiscal year 2013 to -$169.8M in fiscal year 2024.
What was Cidara Therapeutics, Inc.'s net income in the most recent quarter?
Cidara Therapeutics, Inc. (CDTX) reported -$83.2M in net income in Q3 2025. This represents a decrease of 420.7% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Cidara Therapeutics, Inc. (CDTX) reported on that line in every period on record.